Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Mid-range Performer
1424.8000 19.10 (1.36%)
NSE Dec 19, 2025 15:31 PM
Volume: 169.8K
 

1424.80
1.36%
Sharekhan
Ipca Laboratories Limited’s (Ipca) earnings came above our estimates, as sales grew 32.9% y-o-y to Rs. 2,092 crore. Sales growth was led by 11.6% y-o-y growth in domestic branded formulations.
Ipca Laboratories Ltd. has an average target of 1595.00 from 3 brokers.
More from Ipca Laboratories Ltd.
Recommended